Doseloop Beta

Methimazole

medication Under review

An antithyroid medication used to treat hyperthyroidism by reducing the amount of thyroid hormone produced by the thyroid gland.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence supports methimazole's effectiveness in treating hyperthyroidism, particularly in Graves' disease patients, with long-term low-dose therapy showing high remission rates and low relapse when continued. Studies demonstrate it restores euthyroidism, reduces goiter size, and maintains thyroid control with minimal adverse effects in most cases, though close monitoring is required due to potential serious side effects like agranulocytosis. Research consensus affirms its safety and efficacy for extended use in hyperthyroid patients unsuitable for other interventions, with immunological benefits observed alongside thyroid normalization.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (4 studies)

RCT

Long-term, low-dose methimazole therapy is effective in protecting against relapse of Graves’ disease

Clinical Thyroidology for Patients • 2023 • n=184

Not specified in source

RCT

Methimazole - StatPearls

NCBI Bookshelf • 2023

Not specified

Preliminary

The efficacy of long term thyrostatic treatment in elderly patients with toxic nodular goitre compared to radioiodine therapy with different doses.

StatPearls reference • 2023

Not specified

Preliminary

Methimazole Tablets Label

FDA • 2012

FDA

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 2
Side effects noted 1